For Immediate Release

 

CONTACT:

Lauren Geloso

Fujifilm

(914) 789-8303)

lgeloso@fujifilm.com

 

FUJIFILM HOSTS DISTINGUISHED PANEL TO EXPLAIN NEW OREGON BREAST DENSITY LAW AND IMPORTANCE OF BREAST CANCER SCREENING

Efforts will raise awareness of new law and educate women and physicians about breast density and breast cancer risks

Stamford, C.T., and Bothell, Wash., May 8, 2014According to the American College of Radiology Imaging Network (ACRIN), 40% of all women undergoing screening mammography have dense breast tissue. FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and FUJIFILM SonoSite Inc., the world leader in point-of-care (POC) ultrasound, will sponsor an educational symposium titled Navigating through the Dense Breast Imaging Landscape” on May 8, 2014 from 6:00 – 8:30 PM at the Multnomah Athletic Club in Portland, Oregon. 

A panel of thought leaders from leading healthcare organizations plus Oregon State Senator Elizabeth Steiner-Hayward -- will discuss the new breast density law that requires physicians to inform their patient if they have dense breast tissue. Oregon is among the fifteen states now requiring breast density notification.

The symposium will address the importance of an integrated and collaborative approach between providers and patients using mammography and other appropriate screening tools in the diagnosis of breast cancer. A question and answer session will follow at the end of the presentations.  The event will be moderated by former Portland, Oregon news anchor Julie Emry. Panelists will include:

  • Nancy Cappello, PhD

Executive Director and Founder, Are You Dense, Inc.

 

  • Toni Storm-Dickerson, MD

Breast Surgical Oncologist and Co-Director, Compass Oncology

 

  • Amy Thurmond, MD

Diagnostic Radiologist, Women’s Imaging and Intervention and Siker Medical Imaging

 

  • Oregon State Senator Elizabeth Steiner-Hayward, MD

Director, Knight Cancer Institute of Breast Health Education Program, Oregon Health and Science University

 

Fujifilm is dedicated to promoting the early detection of breast cancer through advances in digital mammography as well as supplementary screening or diagnostic testing, including breast ultrasound. Fujifilm continues to conduct research and collaborate with specialists in the field to develop revolutionary and reliable imaging technologies. Over 9,000 worldwide facilities trust Fujifilm's full field digital mammography solutions, making Fujifilm the most popular digital mammography system provider in the world.

For more information, please visit: www.digital-mammography.fujimed.com or www.sonosite.com

About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com  and www.fujifilmendoscopy.com .

 

FUJIFILM SonoSite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by 26 subsidiaries and a global distribution network in over 100 countries. SonoSite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, go to: www.sonosite.com .

 

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 10 companies around the world granted U.S. patents in 2012, and in the year ended March 31, 2013, had global revenues of $26.7 billion*. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com .

 

* At an exchange rate of 83 yen to the dollar.

 

All product and company names herein may be trademarks of their registered owners.